Newman, Nancy J.

The clinical characteristics of pedigrees of Leber’s hereditary optic neuropathy with the 11778 mutation

Newman, N. J., Lott, M. T., & Wallace, D. C. (1991) · American Journal of Ophthalmology

Mitochondrial Function and PathologyGlaucoma and retinal disorders

Cited by 403

Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy

Yu-Wai-Man, P., Newman, N. J., Carelli, V., Moster, M. L., Biousse, V., Sadun, A. A., Klopstock, T., Vignal-Clermont, C., Sergott, R. C., Rudolph, G., et al. (2020) · Science Translational Medicine

Retinal Development and DisordersVirus-based gene therapy research

Cited by 232

International consensus statement on the clinical and therapeutic management of Leber hereditary optic neuropathy

Carelli, V., Carbonelli, M., de Coo, I. F., Kawasaki, A., Klopstock, T., Lagrèze, W. A., La Morgia, C., Newman, N. J., Orssaud, C., Pott, J. W. R., et al. (2017) · Journal of Neuro-Ophthalmology

Mitochondrial Function and PathologyCoenzyme Q10 studies and effects

Cited by 228

Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment

Bennett, J. L., Costello, F., Chen, J. J., Petzold, A., Biousse, V., Newman, N. J., & Galetta, S. L. (2023) · The Lancet Neurology

Multiple Sclerosis Research StudiesOcular Diseases and Behçet’s Syndrome

Cited by 226

Hereditary optic neuropathies: from the mitochondria to the optic nerve.

Newman, N. J. (2005) · American Journal of Ophthalmology

Glaucoma and retinal disordersHereditary Neurological Disorders

Cited by 209

Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset

Newman, N. J., Yu-Wai-Man, P., Carelli, V., Moster, M. L., Biousse, V., Vignal-Clermont, C., Sergott, R. C., Klopstock, T., Sadun, A. A., Barboni, P., et al. (2021) · Ophthalmology

Retinal Development and DisordersVirus-based gene therapy research

Cited by 168

Visual Outcomes in Leber Hereditary Optic Neuropathy Patients With the m.11778G>A (MTND4) Mitochondrial DNA Mutation

Newman, N. J., Carelli, V., Taiel, M., & Yu-Wai-Man, P. (2020) · Journal of Neuro-Ophthalmology

Mitochondrial Function and PathologyGlaucoma and retinal disorders

Cited by 111

Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: Towards improved diagnosis and management

Newman, N. J., Yu-Wai-Man, P., Biousse, V., & Carelli, V. (2023) · The Lancet Neurology

Hereditary Neurological DisordersMitochondrial Function and Pathology

Cited by 97

Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A ND4 Mutation: Systematic Review and Indirect Comparison

Newman, N. J., Yu-Wai-Man, P., Carelli, V., Biousse, V., Moster, M. L., Vignal-Clermont, C., Sergott, R. C., Klopstock, T., Sadun, A. A., Girmens, J.-F., et al. (2021) · Frontiers in Neurology

Virus-based gene therapy researchGlaucoma and retinal disorders

Cited by 64

Patient harm due to diagnostic error of neuro-ophthalmologic conditions.

Stunkel, L., Sharma, R. A., Mackay, D. D., Wilson, B., Van Stavern, G. P., Newman, N. J., & Biousse, V. (2021) · Ophthalmology

Clinical Reasoning and Diagnostic SkillsPatient Safety and Medication Errors

Cited by 54

Biodistribution of intravitreal lenadogene nolparvovec gene therapy in nonhuman primates

Calkins, D. J., Yu-Wai-Man, P., Newman, N. J., Taiel, M., Singh, P., Chalmey, C., Rogue, A., Carelli, V., Ancian, P., & Sahel, J. A. (2021) · Molecular Therapy - Methods & Clinical Development

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 37

Referral patterns in neuro-ophthalmology

Stunkel, L., Mackay, D. D., Bruce, B. B., Newman, N. J., & Biousse, V. (2020) · Journal of Neuro-Ophthalmology

Healthcare Systems and TechnologyOphthalmology and Visual Health Research

Cited by 37

Diagnostic error and neuro-ophthalmology

Stunkel, L., Newman, N. J., & Biousse, V. (2019) · Current Opinion in Neurology

Clinical Reasoning and Diagnostic SkillsRadiology practices and education

Cited by 29

Safety of lenadogene nolparvovec gene therapy over 5 Years in 189 patients with leber hereditary optic neuropathy

VIGNAL-CLERMONT, C., YU-WAI-MAN, P., NEWMAN, N. J., CARELLI, V., MOSTER, M. L., BIOUSSE, V., SUBRAMANIAN, P. S., WANG, A.-G., DONAHUE, S. P., LEROY, B. P., et al. (2023) · American Journal of Ophthalmology

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 25

Cross-sectional analysis of baseline visual parameters in subjects recruited into the RESCUE and REVERSE ND4-LHON gene therapy studies

Moster, M. L., Sergott, R. C., Newman, N. J., Yu-Wai-Man, P., Carelli, V., Bryan, M. S., Smits, G., Biousse, V., Vignal-Clermont, C., Klopstock, T., et al. (2021) · Journal of Neuro-Ophthalmology

Glaucoma and retinal disordersRetinal Development and Disorders

Cited by 7